Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Known as: HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI), HBV NRTI, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2018
012320052018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND To investigate metabolic changes associated with second-line antiretroviral therapy (ART) following virological… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2017
2017
HIV-infected patients exposed to antiretroviral therapy (ART) have an increased risk for hyperlipidemia and cardiovascular… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
Auf dem Kongress der Gesellscha für Phytotherapie 2016 wurde eine aktuelle nicht-interventionelle Studie zur Behandlung von… (More)
Is this relevant?
2015
2015
Nucleoside analog reverse transcriptase inhibitors (NRTIs) are the essential components of highly active antiretroviral (HAART… (More)
  • figure 5
Is this relevant?
2015
2015
EFdA is a potent nucleoside reverse transcriptase inhibitor (NRTI) with activity against a wide spectrum of wild-type and drug… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Is this relevant?
2014
2014
Sterile alpha motif- and histidine/aspartic acid domain-containing protein 1 (SAMHD1) limits HIV-1 replication by hydrolyzing… (More)
Is this relevant?
2014
2014
BACKGROUND Transmission of HIV-1 with drug resistance mutations (DRMs) in Spain remains stable around 13%. However, the profile… (More)
Is this relevant?
2012
2012
Nucleoside reverse transcriptase inhibitors (NRTIs) remain a critical component of therapy for HIV-infected patients. The drugs… (More)
Is this relevant?
2010
2010
BACKGROUND Lipoatrophy can complicate thymidine analogue nucleoside reverse transcriptase inhibitor (tNRTI)-based antiretroviral… (More)
Is this relevant?